Fermi stock analysis: shares near their two-year low with no revenue yet, as an AMD credit deal supports the Project Matador campus.
US Stocks
-
-
Health Care ServicesUS Stocks
Tempus AI Has Grown Revenue 54.6% a Year, but Losses and 27.5 Times Book Value Put the Model at Sell
Tempus AI stock analysis: 54.6% five-year revenue growth, but losses and 27.5x book value leave our scoring model at Sell.
-
Capital MarketsUS Stocks
Hut 8 Grew Revenue 81%, but Free Cash Flow of -$7.7 Billion Keeps the Model at Sell
Hut 8 stock analysis: 81% revenue growth, but -$7.7B free cash flow and 4.37 debt-to-equity keep our scoring model at Sell.
-
US StocksHardware
Seagate Has Fallen 17% in Two Weeks on Rival Capacity Fears, but at 56 Times Earnings the Model Stays at Hold
Seagate Technology stock analysis: revenue up 48.5% and a 17% two-week drop, but 56 times earnings keeps the model at Hold.
-
SoftwareUS Stocks
Snowflake Closes at a Two-Year High After a 7% Jump, but at 24 Times Revenue the Model Still Says Hold
Snowflake stock analysis: product revenue up 37% and a two-year-high share price, but 24 times revenue keeps the model at Hold.
-
Capital MarketsUS Stocks
Soluna Holdings Closes Below $1 as Its Share Count More Than Doubles This Year – and Its Hold Signal Rests on Faulty Data
Soluna Holdings stock analysis: revenue up 145%, but deep losses, heavy dilution and faulty Yahoo data sit behind its Hold signal.
-
PharmaceuticalsUS Stocks
Hims & Hers Jumps 10% in a Day, but Losses, an FTC Lawsuit and Thin Cash Flow Keep the Model at Hold
Hims & Hers Health stock analysis: revenue up 38%, but losses, an FTC lawsuit and a faulty cash flow figure keep the model at Hold.